BRANDI BREUER: Open Payments
NPI 1548710858 · SCHERTZ, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,267 in 117 payments from 17 companies in 2025. Trend: 2023 $553 · 2024 $1,460 · 2025 $1,267
Food & beverage: $1,267
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $556 |
| PFIZER INC. | 30 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $149 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Amgen Inc. | 3 | $45 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Lundbeck LLC | 1 | $17 |
Products named: VRAYLAR, NURTEC ODT, Kerendia, UBRELVY, QULIPTA, Symbravo, SHINGRIX, ELIQUIS.
Industry payments across TX — which companies pay providers there.
